Bibiana Ferreira, CBMR researcher, won recently a Terry Fox Grant with the project “Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma”.
The project has been selected for funding by Liga Portuguesa Conta o Cancro.
The Terry Fox Program provides support to researchers conducting independent high-quality investigations in a complex area of cancer research. The purpose is to stimulate group interaction based on the premise that high impact work in complex areas of cancer research requires collaboration. The Terry Fox prize is designed for researchers with complementary skills, who investigate different aspects of a given cancer relevant topic, the results of which will be realized more rapidly and efficiently than if the individual projects were to be funded as a series of independent operating grants.
CBMR is distinguished with this prize for the fourth time, having been awarded, in previous years, the research projects of Wolfgang Link, Nuno Rodrigues dos Santos and Ana Luísa Martins Ferreira.
Congratulations, Bibiana! CBMR wish you the greatest success in this new project!